Comments

Tryptamine Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Tryptamine Therapeutics (TYPTF) operate in?

Tryptamine Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the OTCPK.

TYPTFOTCPK

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.0111

-0.00390-26.00%

At close: -

Tryptamine Therapeutics (TYPTF) Forecast

News Earnings Tryptamine Therapeutics (TYPTF) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Tryptamine Therapeutics Stock Price, Quotes and Forecasts | OTC:TYPTF | Benzinga

Explore Tryptamine Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for TYPTF.

Open	$0.01
Close	$0.01
Volume / Avg.	104.05K / 30.85K
Day Range	$0.01 - $0.01
52 Wk Range	0.00 - 0.04
Market Cap	$15.97M
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	-

Recent News

Tryptamine Therapeutics Advances Psilocin-Based IV Infusion To Phase 2 Clinical Trials

Tryptamine Therapeutics advances TRP-8803, an IV psilocin therapy with rapid onset and enhanced safety, to Phase 2 clinical trials.

Juan Spínelli

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$0.01
Close	$0.01
Volume / Avg.	104.05K / 30.85K
Day Range	$0.01 - $0.01
52 Wk Range	0.00 - 0.04
Market Cap	$15.97M
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	-

About

Sector

Healthcare

Industry

N/A

Tryptamine Therapeutics Ltd is a clinical-stage biotechnology company focused on bringing transforma...

Got Questions? Ask

How is TYPTF's EV/EBITDA ratio?

What is TYPTF's 7 days volume trend?

What is TYPTF's average daily volume?

What is the Pivot support level for TYPTF?

What’s the latest news on TYPTF?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Tryptamine Therapeutics (TYPTF) stock?

You can purchase shares of Tryptamine Therapeutics (OTCPK:TYPTF) through any online brokerage.

View our list of the best stock brokerages

Who are Tryptamine Therapeutics (TYPTF) competitors?

There are no as such competitors for Tryptamine Therapeutics.

What is the forecast, or price target, for Tryptamine Therapeutics (TYPTF) stock?

There is no analysis for Tryptamine Therapeutics to provide a consensus price target.

What is the current price for Tryptamine Therapeutics (TYPTF)?

The stock price for Tryptamine Therapeutics (OTCPK: TYPTF) is $0.0111 last updated May 1, 2025 at 2:12 PM EDT.

Does Tryptamine Therapeutics (TYPTF) pay a dividend?

There are no upcoming dividends for Tryptamine Therapeutics.

When is Tryptamine Therapeutics (OTCPK:TYPTF) reporting earnings?

Tryptamine Therapeutics does not have any upcoming earnings scheduled.

Is Tryptamine Therapeutics (TYPTF) going to split?

There is no upcoming split for Tryptamine Therapeutics.

What sector and industry does Tryptamine Therapeutics (TYPTF) operate in?

Tryptamine Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the OTCPK.